To evaluate the percentage of subjects that reach the diabetic hypertensive blood pressure
goal of <130/80 with amlodipine versus placebo in subjects initially treated with quinapril
or losartan.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.